26 October 2016 - Carole Longson and others from NICE welcome the authors’ creative ideas on the appraisal of cancer drugs.
But they are wrong to imply that the Cancer Drugs Fund exists only to support observational data collection.
Read BMJ letter
Read letter from Anthony Hatswell (BresMed)